Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Terrafame pursues annual savings of EUR 10 million and initiates change negotiations

Terrafame follows a model of continuous improvement, actively seeking ways to enhance its profitability. The challenges seen in the electric vehicle market in 2023, especially in the Chinese market, have also affected Terrafame’s battery chemicals business. Terrafame has decided to initiate a profitability programme, aiming for EUR 10 million in annual savings. The goal is to improve the company’s international competitiveness and profitability. The company is currently implementing significant investment programmes, which are necessary for the continuation of its operations and

Form 8.3 - Mondi Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------------------+------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------------------------+------------------+|(b) Owner or controller of interests and short positions |  ||disclosed, if different from 1(a):

Heimstaden Appoints Eva Møland Tørsleff as New Chief Legal Officer

Eva Møland Tørsleff brings over 27 years of expertise in Nordic real estate as she joins Heimstaden as Chief Legal Officer 1 March 2024.Eva is a lawyer admitted to the Danish High Courts and Commercial High Court, earned her Master of Law from the University of Aarhus in 1996. She comes from the position as Head of Legal at Nordstern, and also carries experience from renowned Danish firms such as Plesner and Accura. Eva Møland Tørsleff comments:“I am thrilled about the opportunity to join Heimstaden, Europe's leading residential real estate company. Their ambitious goals in governance,

Pimatic Oy celebrates 50th anniversary

Pimatic Oy, a global leader in providing high-quality customized pneumatic solutions, is proud to celebrate its 50th anniversary this year. Established in 1974 in Huittinen, Finland, Pimatic has emerged as a trusted name in the industry, with a strong presence worldwide.Pimatic develops, manufactures, delivers, and services components, actuators, and systems for applied pneumatics and low-pressure hydraulics. It has been at the forefront of applied pneumatics since its inception, and its continued success can be attributed to its dedication to providing innovative solutions for various

Merus Power Plc's Annual Report, Sustainable Report and Remuneration Report 2023 published

Merus Power Plc, Company Announcement, 21.2.2023 klo 12.00   Merus Power Plc has today published its Annual Report, Sustainable Report, and Remuneration Report 2023. The annual report contains a business review, the financial statements, and the board of directors’ Report.   The Annual Report, Sustainable Report, and Remuneration Report are available as PDF files attached to this release and on the company's website at https://sijoittajat.meruspower.fi/en/for-investors/reports-and-presentations/.   Merus Power Plc Board of Directors     For more information

Japanese Patent Office Issues Decision to Grant Patent for EndoDrill Technology

The cancer diagnostics company BiBBInstruments AB ("BiBB" or the "Company"), the developer of the world's first market-cleared electric-driven endoscopic core biopsy instrument, announces that the Company has received a Decision to Grant from the Japan Patent Office (JPO). This means that JPO has decided to approve the Company's first patent application in Japan for EndoDrill[®]. A few additional formal steps will follow before a patent is finally issued, after which the granted patent will be valid until October 2039.BIBB has received a Decision to Grant from the JPO for its patent

Balder announces tender offer regarding outstanding hybrid capital securities

Fastighets AB Balder (publ), via its subsidiary Balder Invest AB, has today announced an invitation to holders of the hybrid capital securities, EUR 500 million 5.25 year non-call, first reset date 2 June 2026 (ISIN: XS2305362951) to tender their hybrid capital securities for purchase by Balder Invest AB for cash up to an aggregate principal amount of EUR 100 million (the “Tender Offer”). The Tender Offer for the hybrid capital securities will be priced via an unmodified Dutch auction procedure with a minimum purchase price of 89.00 per cent. Expiration of the Tender Offer will be 17.00

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 41 – 21 FEBRUARY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Invitation to Clas Ohlson’s Q3 presentation on 6 March

Clas Ohlson will publish its interim report for the third quarter 2023/24 on 6 March at 7:00 a.m. CET. A webcasted presentation of the report will be held at 9:00 a.m. CET the same day.Clas Ohlson invites investors, financial analysts and the media to a webcasted presentation of the interim report for the third quarter 2023/24 on Wednesday 6 March at 9:00 a.m. CET where President and CEO Kristofer Tonström and CFO Pernilla Walfridsson will comment on the report. The interim report for the period May to January 2023/24 will be published at 7:00 a.m. CET and the report and presentation

SEB’s The Green Bond report: darkest before dawn

In the latest issue of SEB’s The Green Bond report, we look at why transition investment has levelled off and explain why a renewed decline in prices across the transition supply chains suggests the setback will be temporary. The fact that sustainable debt transactions and clean energy equities have both bottomed out support this optimistic scenario. Last month was the strongest ever January for new sustainable debt transactions, with total issuance rising 14% from 2023.    “2023 still looks like a missed opportunity when it comes to the energy transition,” says Thomas Thygesen, Head of

Bawat Water Technologies AB: BAWAT Announces Q4 Report 2023

Hørsholm, Denmark, February 21, 2024 – Bawat Water Technologies AB (BAWAT) today announces its Q4  Report for 2023. The report is available on Bawat’s website (investor.bawat.com) BAWAT is a leading supplier of sustainable ballast water treatment technology and services. BAWAT was listed on Nasdaq First North Premier Growth Market in Stockholm in March 2022. Doubling Order Intake and profit margin Y-o-Y and Full year 2024 guidance   Q4 2023 · Order intake in Q4 2023 elevated the full year order intake to SEK 41.8m (Guidance SEK 40-50m), a significant 131% increase from

Annual General Meeting of AB Volvo

AB Volvo (publ) (“Volvo”) gives notice to attend the Annual General Meeting at Konserthuset, Götaplatsen, Göteborg, Wednesday, March 27, 2024, at 3.00 p.m.Volvo warmly welcomes its shareholders to the Annual General Meeting. The main entrance of Konserthuset opens for registration at 2.00 p.m. and the Annual General Meeting begins at 3.00 p.m. Coffee and cakes will be served in connection with the Annual General Meeting. A shareholder may participate in the Annual General Meeting at the venue (in person or represented by a proxy) or through advance voting (postal voting). Please see the

GJF01 - Key information relating to partial redemption of bond issue

Issuer: Gjensidige Forsikring ASAISIN of bond loan: NO0010720378Date of redemption: 28 February 2024Redemption amount: MNOK 263Outstanding loan amount after redemption: MNOK 241Redemption price: 100.364 The buy-back of NOK 263 million of GJF01 will be done in conjunction with the issuance of a new subordinated Tier 2 bond issue (ISIN: NO0013167189) on 28 February 2024. The partial buy-back will be written down in the CSD (no: VPS), provided that the new bond issue has been paid in. This information is published in accordance with the requirements of the Continuing

PhenoSys now offers Turnkey Mini2P Systems with poLight ASA Tunable Optics

Miniature two-photon microscope enables fast, high-resolution, multi-plane calcium imaging for neurological research in freely moving animalsHORTEN, Norway -- 21 February, 2024 -- poLight ASA  (OSE: PLT) today announced that PhenoSys , a leader in engineering and market innovative technology for animal behaviour research, offers a Mini2P turnkey solution that includes TLens® for optimal microscopic imaging. The PhenoSys system includes the miniature two-photon (Mini2P) microscope body for X-Y-Z plane scanning, fiber

Invitation to presentation of Sectra’s nine-month interim report 2023/2024

Linköping, Sweden – February 21, 2024 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) invites investors, analysts, and the media to a presentation of the company’s nine-month report with President Torbjörn Kronander and CFO Jessica Holmquist.Publication of the financial report: 8:15 a.m. (CET) on March 8, 2024Report presentation: 10:00 a.m. (CET) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q3report2324 .  The

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 21.02.2024, 10.35 AMManagers' transactionsViking Line Abp has on February 20:th 2024] received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from aperson discharging managerial responsibilities in Viking Line Abp.Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Jakob JohanssonPosition: Member of the Board/Deputy member Issuer: Viking Line AbpLEI: 743700CUWGW42AGIDN49Notification type: INITIAL NOTIFICATION

Mexican ceramic industry giant invests in airborne water recovery to save nearly half of plant’s total water

Grupo Lamosa, one of the largest ceramics producers of the world, has purchased a system for recycling of airborne wastewater from Swedish water innovation company Drupps to be installed at one of its production plants in Peru, to achieve sustainability ambitions by increasing water efficiency and to ensure the plant's long term operational viability.Grupo Lamosa, one of the largest ceramics producers of the world, has purchased a full-scale Drupps Vapor system for recovery of water from airborne wastewater, to be installed at one of its ceramic tiles production plants in Peru.  The

Swedish psychometric test to transform Mexico's recruitment market

Companies in Mexico and Latin America face significant challenges, including high turnover of employees and low employee engagement. Jobmatch Sweden and the Mexican HR company Mia Meraki have entered into a strategic partnership to promote innovative solutions addressing these challenges and fostering sustainable recruitment processes. "Unique to Jobmatch Talent is that the test focuses on work performance and a high predictive validity. Mia Meraki identified this as a strategic opportunity to enhance its recruitment methodology in Mexico," says Klaus Olsen, CEO of Jobmatch Sweden.

PHI to BioStock: “We aim to revolutionize the regenerative medicine market “

A year ago, Patrik Eschricht assumed the role of CEO at PHI, heralding the shift towards regenerative medicine and a commitment to enhancing shareholder value. This transition was further underscored by the entry of private Swiss distributor and investment company Altium as a major shareholder. BioStock talked to Patrik Eschricht to reflect on the past year and explore his vision for the company’s future.Read the full interview with Patrik Eschricht at biostock.se: https://www.biostock.se/en/2024/02/phi-we-aim-to-revolutionize-the-regenerative-medicine-market/ This is a press release

Comintelli AB: Comintelli signs agreement with new North American customer

Stockholm, Sweden – February 21, 2024 – Comintelli AB (publ), a provider of the software platform Intelligence2day® for market intelligence and analysis, has signed a one-year license agreement with a North American technology company. The order value is USD 70k, which corresponds to ARR (Annual Recurring Revenue). "This agreement marks an important milestone in our SaaS journey and strengthens our position in the North American market," says Jesper Martell, CEO of Comintelli. "The technology industry is a strategically important industry for us and we see a strong demand for our

Taking stock: Women are leading on household budgets but not making future investments shows study

  A study has found that whilst women are leading on budget management and day to day financial planning, they are not investing for the future and less likely than men to invest in stocks and shares. The research by Readly, the digital magazine and newspaper app, reveals how Brits tackle budgeting and financial management and highlights the most popular savings and investment opportunities.   Two thirds of Brits (76 percent) consider themselves to be financially literate and engaged in financial management yet the majority are only saving between £100-500 a month and

ExpreS2ion’s Associated Company AdaptVac Receives Milestone Payment Following Completion of Bavarian Nordic’s Clinical Phase III Study for the COVID-19 Vaccine

Hørsholm, Denmark, 21 February 2024 – ExpreS[2]ion Biotech Holding AB’s affiliate ExpreS[2]ion Biotechnologies ApS (“ExpreS2ion") today announces that AdaptVac ApS (“AdaptVac”) has received 10 million EUR as a result of Bavarian Nordic having completed the clinical Phase III study of the COVID-19 vaccine ABNCoV2. The board of AdaptVac, in line with authority granted through AdaptVac’s articles of association, has agreed to resolve on the pay-out of excess capital in AdaptVac to the shareholders of AdaptVac, which are ExpreS2ion (34% share ownership) and NextGen Vaccines Holding ApS (“NextGen”)

There are no items matching the current filter
There are no more items matching the current filter
Back to top